Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Transactions UK
-
April 08, 2024
UK Oil Biz To Buy Kazakhstan Energy Co. For $15M
Caspian Sunrise PLC, an oil and gas exploration and production company based in Kazakhstan, said Monday it has agreed to buy CS Energy LLP, which holds licenses in the West of the central Asian country, for up to $15 million.
-
April 08, 2024
Biotech Biz Sensorion Raises €15M From Existing Investors
French biotech firm Sensorion SA said Monday that it has raised €15 million ($16.2 million) through a share offering to existing institutional investors to fund its research and development until the end of 2025.
-
April 08, 2024
Real Estate Co. Buys Sites For €110M, Sells UK Asset
Sirius Real Estate, a multinational workspace owner and operator, said Monday that it has finalized four acquisitions in Germany and the U.K. at a price of approximately €110 million ($119 million) as the group seeks to grow in the "highly attractive" regions.
-
April 08, 2024
Linklaters Guides Cosmetics Biz On €1.25B Raise In EU IPO
Cosmetics group Puig, which owns the beauty brand Charlotte Tilbury, said on Monday that it plans to raise more than €1.25 billion ($1.35 billion) through a flotation in Spain, in a sign of revival for European equity capital markets.
-
April 15, 2024
Hill Dickinson Hires 2 Teams From Irwin Mitchell
Hill Dickinson LLP has recruited two groups of real estate specialists from Irwin Mitchell LLP for its new office in Birmingham after a corporate team made a similar move earlier in the year.
-
April 05, 2024
Allianz Selling Mid-Size, Entertainment Holdings In $1.4B Deal
Allianz Group said Friday that its corporate and specialty insurance unit is selling off its U.S. insurance business for midsize corporations and entertainment businesses for $450 million in cash to Arch Insurance North America.
-
April 05, 2024
Korean Trade Promoter Wins Claim Despite Kickback Bid
A South Korean trade agency unfairly dismissed a London-based employee of over 20 years — but won't have to pay him a dime after he tried to negotiate a secret commission, an employment tribunal has ruled.
-
April 05, 2024
Exec Wins £61K After Being Forced To Quit Following Merger
A bedding company must pay its former managing director £61,000 ($77,000) after it forced him to quit following a merger by backtracking on his benefits under the deal, and blocking him from entering the premises, a tribunal has ruled.
-
April 05, 2024
UK Litigation Roundup: Here's What You Missed In London
This past week in London has seen the BBC sued by former Georgian defense minister David Kezerashvili, Russian businessman Ildar Sharipov file a defamation claim against the publisher of the Liverpool Echo newspaper, MEX Group Worldwide sue Barclays and NatWest, and a climbing gear company hit retailer Next with a claim of copyright infringement. Here, Law360 looks at these and other new claims in the U.K.
-
April 05, 2024
Rothesay Sees 'Unprecedented' Pipeline For Pension Deals
Pension insurer Rothesay Life said Friday it secured £12.7 billion ($16 billion) in new business premiums across a dozen de-risking retirement savings deals in 2023, with the year ahead marked by an "unprecedented pension risk transfer market pipeline."
-
April 05, 2024
Allens-Guided Experian To Acquire Peer Illion For $540M
Experian PLC has agreed to buy Australasian rival credit analyst illion for up to $820 million Australian dollars ($540 million), as the Ireland-based global financial data specialist moves to bolster its presence in the region's growing credit reporting market.
-
April 05, 2024
Cloud Biz Denies Owing Telecom Execs Over Bad Sale
A cloud technology business has denied owing directors of a telecommunications company £1.5 million ($1.9 million) left unpaid after it bought their business, claiming the money due is offset by the £2 million it lost from the sale.
-
April 19, 2024
Fieldfisher Expands Pensions Practice With 4 PwC Hires
European law firm Fieldfisher LLP has announced it is bolstering its U.K. pensions practice by hiring a partner, two directors and an associate from PwC UK.
-
April 05, 2024
French Shipping Giant's £605M Offer For Wincanton Lapses
Wincanton PLC said on Friday that an attempt by Ceva Logistics, a subsidiary of French shipping giant CMA CGM SA, to buy the British supply chain group for £605 million ($764 million) has expired.
-
April 05, 2024
US Food Processor JBT Preps €3.5B Bid For Icelandic Rival
Food-processing technology giant JBT Corp. said on Friday that it plans to make a recommended €3.5 billion ($3.8 billion) offer for Icelandic rival Marel HF in May.
-
April 04, 2024
Novo Holdings, Catalent Reset Review Clock On $16.5B Deal
Novo Nordisk Foundation has given the Federal Trade Commission more time for an initial review of Novo Holdings' plan to acquire Catalent in a deal that values the pharmaceutical services company at $16.5 billion.
-
April 04, 2024
Mayer Brown Adds Former KPMG Tax Specialist In London
Mayer Brown has added a former KPMG tax professional to its London office to advise clients on asset management and fund matters in the U.S., Europe and the Middle East, the firm announced.
-
April 04, 2024
Auto Engineering Firm Dowlais Begins £50M Share Buyback
Slaughter and May-advised Dowlais Group PLC on Thursday kicked off its previously announced share repurchase program worth up to £50 million ($63 million), aimed at lowering its outstanding share capital and rewarding investors.
-
April 04, 2024
Insurer Resolution Life To Buy New Zealand Biz For $247M
Resolution Life said on Thursday that its Australasian arm has agreed to buy Asteron Life, an insurer based in New Zealand, for 410 million New Zealand dollars ($247 million), as the global group eyes entry into the country's growing insurance sector.
-
April 04, 2024
Biopharma Biz Faron Raises €4.8M With Equity Issue
Faron Pharmaceuticals Ltd. said Thursday it has raised €4.8 million ($5.2 million) in a share placing aimed at boosting its finances and supporting its research work.
-
April 04, 2024
STM Wins Regulatory Approval For £4.5M Pension Biz Sale
Financial services company STM said on Thursday that the City watchdog has approved the sale of its self-invested personal pensions unit to its chief executive for £4.5 million ($5.7 million), part of a wider sale of the business.
-
April 04, 2024
Standard Life Bags Insurer's Pension Plan In £95M Deal
Standard Life has completed a £95 million ($120 million) buy-in of a pension scheme sponsored by Brit Insurance in a deal guided by Burges Salmon LLP.
-
April 04, 2024
Mondi £5.1B Offer Deadline For DS Smith Extended
Packaging business DS Smith said Thursday that its rival Mondi PLC has been granted extra time to make a £5.1 billion ($6.5 billion) all-share offer as a bidding war for DS with International Paper Co. continues.
-
April 04, 2024
UK Deepens Probe Into Vodafone-Three Telecoms Merger
Britain's antitrust authority said Thursday that it has launched an in-depth probe into plans by Vodafone and Three to merge their U.K. telecommunications networks to create a £16.5 billion ($21 billion) mobile operator after the companies failed to alleviate competition concerns.
-
April 03, 2024
Genmab Builds Oncology Portfolio With $1.8B Deal
Danish biotechnology company Genmab announced Wednesday that it would acquire private cancer drugmaker ProfoundBio for $1.8 billion in cash, a move set to beef up Genmab's oncology portfolio and position the company as a competitor to other biotech companies that have made similar deals in the antibody drug conjugate space in recent months.